United States Acute Migraine Drugs Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Acute Migraine Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Acute Migraine Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Acute Migraine Drugs Overall Market Size
2.1 United States Acute Migraine Drugs Market Size: 2021 VS 2027
2.2 United States Acute Migraine Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Acute Migraine Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Acute Migraine Drugs Players in United States Market
3.2 Top United States Acute Migraine Drugs Companies Ranked by Revenue
3.3 United States Acute Migraine Drugs Revenue by Companies
3.4 United States Acute Migraine Drugs Sales by Companies
3.5 United States Acute Migraine Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Acute Migraine Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Acute Migraine Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acute Migraine Drugs Players in United States Market
3.8.1 List of Tier 1 Acute Migraine Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 Acute Migraine Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Acute Migraine Drugs Market Size Markets, 2021 & 2027
4.1.2 Triptans
4.1.3 NSAIDs
4.1.4 Others
4.2 By Type - United States Acute Migraine Drugs Revenue & Forecasts
4.2.1 By Type - United States Acute Migraine Drugs Revenue, 2016-2021
4.2.2 By Type - United States Acute Migraine Drugs Revenue, 2022-2027
4.2.3 By Type - United States Acute Migraine Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States Acute Migraine Drugs Sales & Forecasts
4.3.1 By Type - United States Acute Migraine Drugs Sales, 2016-2021
4.3.2 By Type - United States Acute Migraine Drugs Sales, 2022-2027
4.3.3 By Type - United States Acute Migraine Drugs Sales Market Share, 2016-2027
4.4 By Type - United States Acute Migraine Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Acute Migraine Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores
5.2 By Application - United States Acute Migraine Drugs Revenue & Forecasts
5.2.1 By Application - United States Acute Migraine Drugs Revenue, 2016-2021
5.2.2 By Application - United States Acute Migraine Drugs Revenue, 2022-2027
5.2.3 By Application - United States Acute Migraine Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States Acute Migraine Drugs Sales & Forecasts
5.3.1 By Application - United States Acute Migraine Drugs Sales, 2016-2021
5.3.2 By Application - United States Acute Migraine Drugs Sales, 2022-2027
5.3.3 By Application - United States Acute Migraine Drugs Sales Market Share, 2016-2027
5.4 By Application - United States Acute Migraine Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Acute Migraine Drugs Product Description
6.1.5 GSK Recent Developments
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Overview
6.2.3 Teva Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 Teva Acute Migraine Drugs Product Description
6.2.5 Teva Recent Developments
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Overview
6.3.3 Pfizer Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Pfizer Acute Migraine Drugs Product Description
6.3.5 Pfizer Recent Developments
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Overview
6.4.3 Novartis Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 Novartis Acute Migraine Drugs Product Description
6.4.5 Novartis Recent Developments
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Overview
6.5.3 Sun Pharma Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.5.4 Sun Pharma Acute Migraine Drugs Product Description
6.5.5 Sun Pharma Recent Developments
6.6 Grunenthal
6.6.1 Grunenthal Corporation Information
6.6.2 Grunenthal Overview
6.6.3 Grunenthal Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.6.4 Grunenthal Acute Migraine Drugs Product Description
6.6.5 Grunenthal Recent Developments
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Corporation Information
6.7.2 Endo Pharmaceuticals Overview
6.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.7.4 Endo Pharmaceuticals Acute Migraine Drugs Product Description
6.7.5 Endo Pharmaceuticals Recent Developments
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Overview
6.8.3 Merck Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.8.4 Merck Acute Migraine Drugs Product Description
6.8.5 Merck Recent Developments
6.9 J & J
6.9.1 J & J Corporation Information
6.9.2 J & J Overview
6.9.3 J & J Acute Migraine Drugs Sales and Revenue in United States Market (2016-2021)
6.9.4 J & J Acute Migraine Drugs Product Description
6.9.5 J & J Recent Developments
7 United States Acute Migraine Drugs Production Capacity, Analysis
7.1 United States Acute Migraine Drugs Production Capacity, 2016-2027
7.2 Acute Migraine Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Acute Migraine Drugs Supply Chain Analysis
9.1 Acute Migraine Drugs Industry Value Chain
9.2 Acute Migraine Drugs Upstream Market
9.3 Acute Migraine Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Acute Migraine Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Acute Migraine Drugs in United States Market
Table 2. Top Acute Migraine Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Acute Migraine Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Acute Migraine Drugs Revenue Share by Companies, 2016-2021
Table 5. United States Acute Migraine Drugs Sales by Companies, (K Unit), 2016-2021
Table 6. United States Acute Migraine Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Acute Migraine Drugs Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Acute Migraine Drugs Product Type
Table 9. List of Tier 1 Acute Migraine Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Acute Migraine Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Triptans
Table 12. Major Manufacturers of NSAIDs
Table 13. By Type - United States Acute Migraine Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Acute Migraine Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Acute Migraine Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Acute Migraine Drugs Sales (K Unit), 2016-2021
Table 17. By Type - United States Acute Migraine Drugs Sales (K Unit), 2022-2027
Table 18. By Application - United States Acute Migraine Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Acute Migraine Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Acute Migraine Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Acute Migraine Drugs Sales (K Unit), 2016-2021
Table 22. By Application - United States Acute Migraine Drugs Sales (K Unit), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK Acute Migraine Drugs Product
Table 27. GSK Recent Developments
Table 28. Teva Corporation Information
Table 29. Teva Description and Major Businesses
Table 30. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Teva Acute Migraine Drugs Product
Table 32. Teva Recent Developments
Table 33. Pfizer Corporation Information
Table 34. Pfizer Description and Major Businesses
Table 35. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Pfizer Acute Migraine Drugs Product
Table 37. Pfizer Recent Developments
Table 38. Novartis Corporation Information
Table 39. Novartis Description and Major Businesses
Table 40. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Novartis Acute Migraine Drugs Product
Table 42. Novartis Recent Developments
Table 43. Sun Pharma Corporation Information
Table 44. Sun Pharma Description and Major Businesses
Table 45. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Sun Pharma Acute Migraine Drugs Product
Table 47. Sun Pharma Recent Developments
Table 48. Grunenthal Corporation Information
Table 49. Grunenthal Description and Major Businesses
Table 50. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Grunenthal Acute Migraine Drugs Product
Table 52. Grunenthal Recent Developments
Table 53. Endo Pharmaceuticals Corporation Information
Table 54. Endo Pharmaceuticals Description and Major Businesses
Table 55. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 57. Endo Pharmaceuticals Recent Developments
Table 58. Merck Corporation Information
Table 59. Merck Description and Major Businesses
Table 60. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Merck Acute Migraine Drugs Product
Table 62. Merck Recent Developments
Table 63. J & J Corporation Information
Table 64. J & J Description and Major Businesses
Table 65. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. J & J Acute Migraine Drugs Product
Table 67. J & J Recent Developments
Table 68. Acute Migraine Drugs Production Capacity (K Unit) of Key Manufacturers in United States Market, 2019-2021 (K Unit)
Table 69. United States Acute Migraine Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Acute Migraine Drugs Market Opportunities & Trends in United States Market
Table 71. Acute Migraine Drugs Market Drivers in United States Market
Table 72. Acute Migraine Drugs Market Restraints in United States Market
Table 73. Acute Migraine Drugs Raw Materials
Table 74. Acute Migraine Drugs Raw Materials Suppliers in United States Market
Table 75. Typical Acute Migraine Drugs Downstream
Table 76. Acute Migraine Drugs Downstream Clients in United States Market
Table 77. Acute Migraine Drugs Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Acute Migraine Drugs Product Picture
Figure 2. Acute Migraine Drugs Segment by Type
Figure 3. Acute Migraine Drugs Segment by Application
Figure 4. United States Acute Migraine Drugs Market Overview: 2020
Figure 5. United States Acute Migraine Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Acute Migraine Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Acute Migraine Drugs Sales in United States Market: 2016-2027 (K Unit)
Figure 8. The Top 3 and 5 Players Market Share by Acute Migraine Drugs Revenue in 2020
Figure 9. Triptans Product Picture
Figure 10. NSAIDs Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Acute Migraine Drugs Sales Market Share, 2016-2027
Figure 13. By Type - United States Acute Migraine Drugs Revenue Market Share, 2016-2027
Figure 14. By Type - United States Acute Migraine Drugs Price (USD/Unit), 2016-2027
Figure 15. Hospital Pharmacies
Figure 16. Drug Stores
Figure 17. By Application - United States Acute Migraine Drugs Sales Market Share, 2016-2027
Figure 18. By Application - United States Acute Migraine Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - United States Acute Migraine Drugs Price (USD/Unit), 2016-2027
Figure 20. GSK Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Teva Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Pfizer Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Novartis Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sun Pharma Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Grunenthal Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Endo Pharmaceuticals Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Merck Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. J & J Acute Migraine Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Acute Migraine Drugs Production Capacity (K Unit), 2016-2027
Figure 30. Acute Migraine Drugs Industry Value Chain
Figure 31. Marketing Channels